Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Codexis Inc (CDXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Codexis Reports Financial Results for the Third Quarter of 2017

Product sales increase 71% over the prior year

CDXS : 8.50 (-5.56%)
Codexis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 9, 2017 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q3 Earnings Call to be held on November 9, 2017 at 4:30 PM Eastern Time.

CDXS : 8.50 (-5.56%)
Codexis to Present at Two Investment Conferences in November

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two investment conferences in November:

CDXS : 8.50 (-5.56%)
Codexis to Hold 2017 Third Quarter Conference Call on November 9

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report third quarter 2017 financial results after market close on Thursday, November 9, 2017. Codexis management...

CDXS : 8.50 (-5.56%)
Codexis and Nestle Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership

-- Includes an option for the global development of CDX-6114 for PKU, marking Codexis' first partnership for an internally developed biotherapeutic product. Codexis receives an upfront payment of $14...

CDXS : 8.50 (-5.56%)
Codexis to Present at Four Investment Conferences in September

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at four investment conferences in September:

CDXS : 8.50 (-5.56%)
EnzymeWorks, Inc. and Dr. Alex Tao Respond to Press Release by Codexis, Inc.

In response to a recent inaccurate press release by Codexis regarding the case Codexis, Inc. v. EnzymeWorks, Inc., Case No. 3:16-cv-00826-WHO (the "Case"), EnzymeWorks and Alex Tao, Ph.D.,...

CDXS : 8.50 (-5.56%)
Codexis Reports Financial Results for the Second Quarter of 2017

Product sales more than doubled versus prior-year second quarter

CDXS : 8.50 (-5.56%)
Investor Network: Codexis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 9, 2017 at 4:30 PM Eastern...

CDXS : 8.50 (-5.56%)
Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks

Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, on Tuesday secured a federal court order awarding it summary judgment on 10 claims of patent infringement it brought...

CDXS : 8.50 (-5.56%)
Codexis to Hold 2017 Second Quarter Conference Call on August 9

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report second quarter 2017 financial results after market close on Wednesday, August 9, 2017. Codexis management...

CDXS : 8.50 (-5.56%)
Specialty Enzymes Market to Reach US$3,726.4 Million by 2025: Demand for Better Diagnostics Ensures Swift Uptake

Transparency Market Research (TMR) states that Codexis Inc., Biocatalysts Ltd., Amano Enzymes Inc., and Novozymes A/S are the leading players in the global Specialty Enzymes Market. These players are expected...

CDXS : 8.50 (-5.56%)
Codexis Reports Financial Results for the First Quarter of 2017

Product sales increase 49%

CDXS : 8.50 (-5.56%)
Investor Network: Codexis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 9, 2017 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 4:30 PM Eastern Time.

CDXS : 8.50 (-5.56%)
Codexis Announces Pricing of Public Offering of Common Stock

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a public offering price of...

CDXS : 8.50 (-5.56%)
Codexis Announces Proposed Public Offering of Common Stock

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in...

CDXS : 8.50 (-5.56%)

Van Meerten Stock Picks

My 5 Favorite Mid Cap Stocks
This morning I wanted to find 5 Mid Cap stocks that had great returns over the past year and still seem to have some juice left.
KBH -1.63 , IPGP +2.02 , FSLR -2.19 , NVR -17.23 , SGMS +0.25
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 +0.39%) are up +0.41% at a fresh record nearest-futures high as growth optimism fuels gains in global equity markets. Gains in technology stocks are leading the overall market higher as... Read More

Chart of the Day

Chart of the Day

Audentes Therapeutcs (BOLD) is rhe Barchart Chart of the Day.  The biomedical company has a Trend Spotter buy signal, a Weighted Alpha of 174.58+ and gained 111.74% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures bounced back from Friday’s bearish USDA reports to close Tuesday with gains of 2 cents in most nearby contracts. The weekly Export Inspections report indicated just 584,389 MT of corn was shipped during the week of Jan 11. That is ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.